iodinated glycerol has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, JI; Cho, SS; Choi, JS; Kim, E; Kwak, AW; Lee, MH; Lee, SM; Oh, HN; Seo, JH; Seo, KS; Shim, JH; Yoon, G | 1 |
| Chen, C; Fang, D; Huang, S; Jing, Q; Padia, R; Shenoy, AK; Su, SB; Yang, P | 1 |
| Chae, JI; Kim, E; Lee, MH; Oh, HN; Shim, JH; Yoon, G | 1 |
3 other study(ies) available for iodinated glycerol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Dual inhibition of EGFR and MET by Echinatin retards cell growth and induces apoptosis of lung cancer cells sensitive or resistant to gefitinib.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; ErbB Receptors; Gefitinib; Glycyrrhiza; Humans; Lung Neoplasms; Molecular Docking Simulation; Plant Roots; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Quinazolines | 2020 |
Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2', 4'-Tetrahydroxychalcone.
Topics: Actins; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Chalcones; Cytoskeleton; Disease Progression; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Focal Adhesions; Glycyrrhiza; Humans; Lung Neoplasms; Mice; Mice, Nude; Plant Extracts; Random Allocation; src-Family Kinases; Xenograft Model Antitumor Assays | 2018 |
Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Glycyrrhiza; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Molecular Targeted Therapy; Proto-Oncogene Proteins c-met; Reactive Oxygen Species | 2019 |